Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.720
0.00 (0.00%)
Jan 31, 2025, 12:59 PM EST - Market open
Humacyte Market Cap
Humacyte has a market cap or net worth of $607.32 million as of January 31, 2025. Its market cap has increased by 128.15% in one year.
Market Cap
607.32M
Enterprise Value
666.38M
1-Year Change
128.15%
Ranking
Category
Stock Price
$4.72
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $607.32M, an increase of 388.56%. That is a compound annual growth rate of 46.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2025 | 607.32M | -6.53% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.26B |
| UnitedHealth Group | 502.08B |
| Novo Nordisk | 374.46B |
| Johnson & Johnson | 368.05B |
| AbbVie | 310.40B |
| Merck & Co. | 250.31B |
| Thermo Fisher Scientific | 232.08B |
| Abbott Laboratories | 223.42B |